14th Apr 2014 09:49
LONDON (Alliance News) - Microsaic Systems PLC said Monday that it had signed a pre-contract commercial agreement with a healthcare equipment company to market and sell its 4000 MiD mass spectrometry instrument.
Mass spectrometry is an analytical technique used to produce a sample of material. Under the agreement, the companies will focus on using the 4000 MiD for protein separation.
It will now work towards inking a full commercial contract with the unnamed partner by the end of 2014. It expects to sign a contract for the purchase of up to 50 units and consumables of the 4000 MiD in the first year, rising to over 200 units and consumables from the fourth year.
Microsaic said that the selling price is in line with expectations, and it expects to begin shipments in the first quarter of 2015. It provided no further financial details.
"We believe that our unique 4000 MiD system has the potential to make mass spectrometry more accessible to lab scientists than ever before, thereby opening up new opportunities across a wide range of applications and formats," said Chief Executive Colin Jump in a statement.
It said the unnamed partner is a "major" international healthcare equipment company.
Shares in Microsaic were trading down 6.4% at 45.75 pence Monday.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Microsaic